Back to companies
Acrivon Therapeutics, Inc.
ACRVUSNASDAQPharmaceuticals & HealthcareAcrivon Therapeutics, Inc.
Revenue
—
FY2025
Operating income
-$84.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API